Abbott | ABT - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Abbott USD 4.27B 669M 2026-09
Agilent USD 475M 10M 2026-06
AtriCure USD 82.88M 319K 2026-09
Baxter International USD 730M 5M 2026-09
Becton, Dickinson and Co. USD 1.26B 1000K 2026-09
Bio-Rad Laboratories USD 212M 400K 2026-06
Boston Scientific USD 1.68B 120M 2026-09
Cooper Companies USD 401.3M 274.9M 2026-06
Danaher USD 2.16B 87M 2026-09
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 560.9M 300K 2026-09
Globus Medical USD 288.47M 1.65M 2026-09
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
J&J USD 6.25B 168M 2026-09
Medtronic 3.2B 141M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Pfizer USD 3.28B 132M 2026-09
Smith & Nephew USD 1.45B 29M 2026-06
Solventum Corp USD 813M 114M 2026-09
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 113.94M 2.3M 2026-09
Teleflex USD 220.72M 7.21M 2026-09
Terumo JPY 109.58B 120M 2026-09
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Zimmer Biomet Holdings USD 855M 56.6M 2026-09